Evaluation of seroepidemiological toxoplasmosis in HIV/AIDS patients in the south of Brazil by Xavier, Graciela Augusto et al.
Rev. Inst. Med. Trop. Sao Paulo
55(1):25-30, January-February, 2013
doi: 10.1590/S0036-46652013000100005
Institut of Biology, Departament of Microbiology and Parasitology, Federal University of Pelotas, Rio Grande do Sul, Brazil.
Correspondence to: Beatris Gonzalez Cademartori, Rua Apolinario Porto Alegre 423, 96080-010 Pelotas, RS, Brasil. E-mail: biacademartori@yahoo.com.br
EVALUATION OF SEROEPIDEMIOLOGICAL TOXOPLASMOSIS IN HIV / AIDS PATIENTS  
IN THE SOUTH OF BRAZIL
Graciela Augusto XAVIER, Beatris Gonzalez CADEMARTORI, Nilton Azevedo da CUNHA FILHO & Nara Amélia da Rosa FARIAS
SUMMARY
Toxoplasmosis is considered one of the opportunistic infections for individuals with the Acquired Immunodeficiency Syndrome 
(AIDS), and is also a major cause of morbidity and mortality. The aim of this study was to evaluate the prevalence of neurotoxoplasmosis, 
ocular toxoplasmosis and antibodies for Toxoplasma gondii in HIV-positive patients attending the SAE (Specialized Assistance 
Service for HIV/AIDS), as well as to associate their serological profile with epidemiological and clinical data. A total of 250 
patients participated in the study from December, 2009 to November, 2010. Serological analysis was performed using the indirect 
immunofluorescent technique; epidemiological data were gathered by a questionnaire, and clinical history was based on the analysis 
of medical charts. Prevalence of seropositivity was 80%, with history of neurotoxoplasmosis in 4.8% and of ocular toxoplasmosis in 
1.6% of the patients. The Highly Active Antiretroviral Treatment (HAART) was not used by 32% of the patients, 18.4% of the patients 
had CD4+ T- lymphocyte count less than 200 cells/mm3 and 96.8% of them were not aware of the modes of disease transmission. 
These findings led us to conclude that the study population is at high risk of clinical toxoplasmosis, because of both reactivation of 
infection in the seropositive patients who do not make a regular use of HAART, and primo-infection in seronegative patients worsened 
by an unawareness of the modes of infection reported in this study. 
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INTRODUCTION
Infection by Toxoplasma gondii has high prevalence among humans 
and animals. Although it is usually asymptomatic in immunocompetent 
people, the protozoan can cause severe disease in fetuses and in 
immunodepressed individuals30.
In immunocompetent people, after the development of an appropriate 
immune response, the acute infection becomes chronic, characterized 
by the presence of tissue cysts that remain dormant29. However, in 
immunodepressed individuals there may be a reactivation of the infection 
through the rupture of the cysts, causing severe pathology which can 
lead to death6.
Cerebral toxoplasmosis, in AIDS patients, is the most common 
opportunistic infection, appearing when the levels of CD4+ T- 
lymphocytes are under 200 cells/mm3, toxoplasmic retinochoroiditis 
is also one of the important secondary ocular inflammations in these 
patients15. Neurological lesions were found in up to 90% of the 
pathological examinations with AIDS 30.
Even with the use of HAART (Highly Active AntiRetroviral 
Treatment), neurotoxoplasmosis remains the prevalent cause of 
neurological disorders in HIV-positive patients, being particularly 
severe among those with higher immunosupression and an absence of 
prophylaxis2. 
Around 95% of patients with cerebral toxoplasmosis present 
detectable levels of IgG anti-T. gondii serum antibodies25. Thus, it is 
extremely important that serology for Toxoplasma gondii be performed, 
so that, with an early diagnosis, the person can receive the appropriate 
treatment in order to prevent the reactivation of the disease.
This work aimed to verify the prevalence of antibodies for T. gondii, 
neurotoxoplasmosis and ocular toxoplasmosis in HIV-positive patients in 
care of a Reference Service (SAE) in the south of Brazil, by correlating 
seropositivity with the epidemiological and clinical data of each patient.
MATERIALS AND METHODS
A cross-sectional study was conducted, involving 250 HIV-positive 
patients who were under medical supervision at the Specialized 
Assistance Service for HIV/AIDS (SAE), linked to the Medicine College 
of the Federal University of Pelotas (UFPel) from December 2009 to 
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November 2010. The SAE is a reference center for the treatment of people 
infected with HIV in the region of Pelotas (31°46'19"S, 52°20'34"W), 
in the state of Rio Grande do Sul (Brazil).
All the patients signed the Statement of Free and Clarified Consent 
after an explanation about the research would entail.
To verify the determining factors in the risk of transmission of the 
disease, the patients answered a questionnaire about sex, age group, 
level of education, residence in rural area, knowledge about the disease, 
ignorance about ways of transmission of the disease, living with cats, 
presence of cats in the peridomicile, the habit of handling raw meat, the 
habit of eating raw vegetables, raw/undercooked meat and homemade 
sausages, the habit of drinking unpasteurized milk and untreated water, 
having meals in restaurants, not regularly washing hands before meals, 
direct contact of hands with soil and blood transfusion history.
The data of cerebral toxoplasmosis, ocular toxoplasmosis, levels 
of CD4+ T- lymphocytes, CD4/CD8, viral load quantification and 
antiretroviral therapy use were obtained using the patients’ medical 
records.
The blood used for the study was collected by venipuncture in 
the Clinical Analysis Laboratory at the Medicine College, and then 
centrifuged, with the serum being stored at -20ºC in Ependorff tubes, 
and all properly identified. The serological analysis was performed at the 
Parasitology Laboratory of the Biology Institute of UFPel.
The technique used to detect the antibodies IgG and IgM for T. 
gondii was Indirect Immunofluorescence Assay (IFAT) – (WAMA® 
Diagnostica), according to the manufacturer’s instructions, and the 
samples were considered reactive when they were diluted from 1:32 on.
The sample size was calculated based on the number of HIV-positive 
patients being followed at the SAE, with a prevalence expectation of 50%, 
5% error and confidence level of 95%, reaching a minimum sample size 
of 249 patients to be evaluated. The number of samples analyzed was 250.
The calculation of the sample size and the analysis of the results were 
assessed using Epi-Info version 6.04 and the Chi-square test was also 
performed, differences were considered statistically significant when p 
< 0.05. The value of OR (Odds Ratio) was determined with a confidence 
interval of 95%. As for risk factors, only those which presented p ≤ 0.25 in 
the bivariate analysis were included in the multivariate model performed 
by the program Statistix 9.0.
ETHICAL CONSIDERATIONS
The Project was submitted to the Committee for Ethics in Research 
with human beings of the Medicine College of UFPel, and was approved 
and registered under number 121/07.
RESULTS
No IgM antibodies for T. gondii were found among the HIV-positive 
patients in the study. 
Seroprevalence was 80% (200/250) (95% CI; 74.7 - 84.6) concerning 
IgG antibodies. The titers ranged from 32 to 512, the one with highest 
frequency being 64 (46.5%). 
For the assessed women and men, seropositivity was 78.1% and 
81.7%, respectively, with no statistically significant difference between 
sexes. The age of the patients ranged from 14 to 73 years old (average 
= 38.6).
It was found that patients were uninformed about the disease, because 
even among those who said they knew about it (70.4%), the lack of 
information about the main ways of transmission was high (95.5%). The 
patients who reported having knowledge about forms of transmission 
were asked about these forms, and the correct associations mentioned 
were: ingestion of raw or undercooked meat, contaminated vegetables 
and fruit and contact with cat feces.
Table 1 shows a significant association (p < 0.05) or not between the 
risk factors and seropositivity for T. gondii of the patients in the bivariate 
analysis. For the multivariate model, this association is shown in Table 2.
Regarding the levels of CD4+ T- lymphocytes, based on the medical 
records of the patients, they ranged between 1 and 1575 cells/ mm3, with 
an average of 405.07 cells/ mm3. Among patients with positive serology 
for T. gondii, the variation was between 12 and 1482 cells/ mm3, with an 
average of 414.11 cells/ mm3, and 15% of them had CD4+ T- lymphocyte 
levels of < 200 cells/mm3.
Table 3 shows frequency of seropositivity related to the levels of 
CD4+ T- lymphocytes, CD4/CD8, viral load and antiretroviral use.
The medical charts showed that 3.6% of the patients (nine cases) 
developed neurotoxoplasmosis, 0.8% (two cases) neurotoxoplasmosis 
associated with ocular toxoplasmosis, 0.8% (two cases) ocular 
toxoplasmosis and 0.4% (one case) neurotoxoplasmosis associated 
with ischemia.
DISCUSSION
The incidence of infection by T. gondii varies within communities, 
depending on dietary habits, contact with animals carrying the protozoan/
parasite and climate conditions11.
The non-detection of IgM antibodies in patients throughout the study 
is indicative that primo-infection by T. gondii has not occurred. However, 
serological tests for IgM antibodies in people with HIV/AIDS are usually 
negative, since their low immunity response may lead them to produce 
antibodies at levels undetectable by these techniques3.
Seroprevalence of 80% found in this study was higher than that 
reported for immunocompetent populations in the same region (54.8% 
for pregnant women10 and 57.5% for blood donors17 in Pelotas-RS and 
59.8% for pregnant women in Porto Alegre-RS28). Seroprevalence in 
immunosuppressed individuals was similar to that reported by other 
studies in Brazil: Pará (82.9%)13 and Bahia (77.3%)23.
However, it was higher than the ones found in Norway (17.8%)12, 
Iran (49.75%)21, Malaysia (44.7%)22 and Africa (31.3%)24. The 
variations in the prevalence of anti-Toxoplasma antibodies found in 
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Table 1
Frequency of the possible risk factors and relation with seropositivity for Toxoplasma gondii in 250 HIV-positive patients in Pelotas, RS, 2009-2010
Variables




n % n %
Direct hand contact with soil 46.8% 103 88 14 12 0.003*
School level < high school 81.2% 169 83.2 34 16.7 0.007*
Consumption of untreated water 39.2% 86 87.8 12 12.2 0.014*
Living with cats 60% 127 84.7 23 15.3 0.024*
Residence in rural area 4% 10 100 0 0 0.102
Consumption of homemade sausages 60.4% 125 82.8 26 17.2 0.174
Consumption of raw or undercooked meat 27.6% 58 84.1 11 15.9 0.322
Ignorance about the disease 29.6% 62 83.8 12 16.2 0.332
Presence of cat in the peridomicile 71.2% 145 81.5 33 18.5 0.364
Meals in restaurants 6.4% 12 75 4 25 0.402
Blood transfusion 24.4% 51 83.6 10 16.4 0.418
Ignorance about ways of transmission 96.8% 194 80.2 48 19.8 0.499
Consumption of raw vegetables 94% 188 80 47 20 0.608
Not washing hands before meals 2.4% 5 83.3 1 16.7 0.655
Age group > 30 years old 72% 145 80.5 35 19.4 0.725
Consumption of unpasteurized milk 24.4% 49 80.3 12 19.7 0.941
Handling of raw meat 86% 172 80 43 20 1.000
* p < 0.05
Table 2
Association (p < 0.05) of the factors of risk of infection by Toxoplasma gondii with the seropositivity in 250 HIV-positive patients, after the application of the 
multivariate model in Pelotas, RS, 2009-2010
Variables
Positive Negative
OR 95% CI p value 
n % n %
School level < High School
Yes 169 83.2 34 16.7
No 31 66 16 34 2.47 (1.20-5.08) 0.0140
Direct hand contact with soil
Yes 103 88 14 12
No 97 7.9 36 27.1 2.66 (1.34-5.26) 0.0049
OR, Odds ratio; CI, confidence interval.
different studies may be related to the risk of infection by the protozoan, 
reflecting the dietary habits and the sanitary conditions of the places 
where these studies were performed. It was found that having a low 
educational level (less than high school) is a risk factor for infection, 
as found in previous research done in Brazil16,18,28. The low level of 
instruction of the analyzed patients explains the lack of knowledge 
about the ways of transmission of toxoplasmosis, in agreement with 
another study conducted in the same city4. This makes it evident that 
improvements in the quality of education are needed, especially because 
the level of instruction lowers the exposure to risks, this is down to 
the adoption of more appropriate measures of hygiene and nutrition 
by the subjects18,28.
Direct manipulation of soil was the factor most associated with the 
infection, and it was also seen in immunocompetent groups (pregnant 
women) in some cities in Rio Grande do Sul4,26. 
It was found that all the patients from rural areas were seropositive 
for T. gondii, which may be due to the higher likelihood of handling soil 
with bare hands, a factor associated with this infection.
XAVIER, G.A.; CADEMARTORI, B.G.; CUNHA FILHO, N.A. & FARIAS, N.A.R. - Evaluation of seroepidemiological toxoplasmosis in HIV/AIDS patients in the south of Brazil. Rev. 
Inst. Med. Trop. Sao Paulo, 55(1): 25-30, 2013.
28
Also, it was discovered that 39.2% of the analyzed patients drank 
untreated water. However, through multivaried analysis, it was found that 
there was no association between this factor and infection by T. gondii, 
agreeing with other studies done in the southern region of Brazil4,18.
Living with cats as pets did not present risk of infection by for T. 
gondii, although this species is the main disseminator of the protozoa 
in the environment because it eliminates oocysts in its feces, and the 
former become infectious after a minimum of 24 hours11. However, 
this association is polemic, since in certain studies living with cats was 
considered a risk factor16,18,26, whereas in others it was not4,7. There are 
authors who claim that there are no impediments for immunosupressed 
people and pregnant women to have cats4,9, as long as basic precaution 
measures are taken3. 
Neurotoxoplasmosis presented low prevalence (4.8%), similar to 
those found by researchers in other countries like Mexico (5.1%)8, 
Norway (8%)12 and Iran (10%)21.
Only 1.6% of the patients developed ocular toxoplasmosis, 
either alone or associated with neurotoxoplasmosis. In São Paulo19, 
this prevalence was 4.4%, and in Recife1 it was 5.7%. Although 
the incidence of opportunistic infections has decreased since the 
introduction of HAART, ocular toxoplasmosis still occurs in patients 
with neurotoxoplasmosis31.
Literature on the subject shows that opportunistic infections/co-
infections is one of the main factors for risk of death in patients affected 
by HIV/AIDS. In the relationship between these infections and the count 
of CD4+ T- lymphocytes, the latter remains as a short term predictor14. 
 In this study, the average count of the CD4+ T- lymphocyte levels 
in patients with neurotoxoplasmosis was 116 cells/mm3, similar to the 
one found in Recife1 (139.8 cells/mm3). On the other hand, more severe 
degrees of immunosupression were found in Mexico8 (78 cells/mm3), 
Norway12 (75 cells/mm3) and Iran21 (66.4 cells/mm3). A significant 
association between neurotoxoplasmosis and CD4+ T- lymphocyte levels 
below 100 cells/mm3 was found, showing that patients with a low number 
of CD4+ cells present a higher risk of reactivation of the infection8. 
The HAART provides a significant improvement in the quality of 
life for HIV-positive people, preventing the weakening of their immune 
system and reducing the appearance of opportunistic infections20. 
The antiretroviral treatment was not used regularly by 32% of patients 
in this study, which is in accordance with data reported in the study 
conducted in Recife29. A total of 9.2% (23/250) of patients had CD4+ 
T- lymphocyte count less than 200 cells/mm3, which means a high risk 
of reactivation of the disease (69.6% seropositives) or primo-infection 
(30.4% seronegatives). Antiretroviral therapy is indicated for HIV-
positive asymptomatic patients who have CD4+ T- lymphocyte count 
between 200 and 350/mm3; and the closer the T- lymphocyte count is 
to 200 cells/mm3, the higher the risk of progression for AIDS and the 
establishment of opportunistic infections20. It is clear that some difficulties 
must be overcome, such as the non-compliance with the treatment and 
the correct use of medication aiming towards improving the quality of 
life and lifespan of these patients26.
The seronegatives for T. gondii have a higher level of schooling, 
better hygiene and food habits (Table 1), which could explain the lack of 
contact with the parasite. These patients had special attention regarding 
explanations about risks of infection and how to prevent it. All subjects 
attending the SAE have been serologically monitored for T. gondii and 
other important opportunistic infection causative agents, since a primo-
infection associated with immunosuppression could cause them death30.
The results of this study highlight the importance of establishing 
primary prevention programs against T. gondii infection in the 
community, so that risks of primo-infection in seronegative individuals 
can be reduced, particularly in those with severe immunosuppression and 
without appropriate treatment. Moreover, all HIV positive patients should 
have the importance of a strict compliance with the medical prescription 
Table 3
Frequency of 250 HIV-positive patients seropositive and seronegative for Toxoplasma gondii, related to the levels of CD4+, CD4/CD8, use of HAART and viral load 





n % n % n %
CD4 < 200 46 18.4 32 69.6 14 30.4
CD4 > 200 204 81.6 168 82.3 36 17.7
CD4/CD8 < 1 229 91.6 181 79 48 21
CD4/CD8 > 1 21 8.4 19 90.4 2 9.6
Detectable viral load (> 50) 126 50.4 98 77.7 28 22.3
Undetectable viral load (< 50) 124 49.6 102 82.2 22 17.8
Regular use of HAART 154 61.6 122 79.2 32 20.8
Irregular use of HAART 16 6.4 11 68.8 5 31.2
No use of HAART 80 32 67 83.7 13 16.3
      Treatment-naive patients 56 70 46 82.1 10 17.9
      Treatment dropouts 24 30 21 87.5 3 12.5
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explained to them, so that their immune system will be able to prevent 
opportunistic infections like the toxoplasmosis, which could be fatal.
RESUMO
Avaliação soroepidemiológica de toxoplasmose em pacientes  
HIV/SIDA no sul do Brasil 
A toxoplasmose é considerada uma das infecções oportunistas em 
indivíduos com a Síndrome da Imunodeficiência Adquirida (SIDA), 
constituindo importante causa de morbidade e mortalidade. Este trabalho 
objetivou conhecer a prevalência de neurotoxoplasmose, toxoplasmose 
ocular e de anticorpos para Toxoplasma gondii, em pacientes HIV 
positivos em atendimento no SAE (Serviço de Assistência Especializada 
em HIV/AIDS) além de correlacionar seu perfil sorológico com dados 
epidemiológicos e clínicos. Foram analisados 250 pacientes no período de 
dezembro de 2009 a novembro de 2010. A análise sorológica foi realizada 
pela técnica de imunofluorescência indireta, os dados epidemiológicos 
foram obtidos pela aplicação de um questionário e o histórico clínico, 
pela análise dos prontuários. A prevalência de soropositividade foi de 
80%, com histórico de neurotoxoplasmose em 4,8% e de toxoplasmose 
ocular em 1,6%. Observou-se que 32% dos pacientes não faziam uso 
regular de HAART, 18,4% apresentaram contagem de linfócitos T CD4+ 
inferior a 200 céls/mm3 e 96,8% desconheciam os modos de transmissão 
da doença. Conclui-se que o risco de toxoplasmose clínica grave é alto na 
população estudada, tanto por reativação da infecção nos soropositivos 
que não fazem uso regular do HAART, quanto por primoinfecção dos 
soronegativos, agravado pela desinformação sobre as formas de infecção 
constatada na pesquisa. 
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